Track the Alligator Bioscience AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Alligator Bioscience AB has recorded 4 reports. Market capitalisation: €140.7m. The latest transaction was reported on 16 September 2025 (Purchase). Among the most active insiders: Peter Ostler. The full history is free.
Analysts rate Alligator Bioscience AB Strong Buy (bullish), based on 1 analysts. Average price target: SEK 0.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations